Schering Corporation

Dendreon Corporation

Pharmacopeia Drug Discovery, Inc.

Schering-plough Corporation

Henry A Vaccaro

Neng-Yang Shih

Zhaoning Zhu

Robert G Aslanian

Kevin D McCormick

Daniel M Solomon

Tin-Yau Chan

Viyyoor Moopil Girijavallabhan

Ashit K Ganguly

F George Njoroge

Anil K Saksena

Frank W Bennett

Stuart B Rosenblum

Ashok Arasappan

Stephane L Bogen

Raymond G Lovey

Kevin X Chen

Yi-Tsung Liu

Odile Esther Levy

Patrick A Pinto

Russell E Pike

Marguerita S Lim-Wilby

Edwin Jao

Haiyan Wang

Tejal Parekh

Scott Jeffrey Kemp

Bama Santhanam

Susan Y Tamura

Srikanth Venkatraman

Michael Berlin

Pauline C Ting

Christopher W Boyce

Manuel De Lera Ruiz

Junying Zheng

Mwangi W Mutahi

Xiaohong Zhu

Jinping L Mc Cormick

John J Baldwin

Ge Li

Wing C Tom

Pietro Mangiaracina

Jianhua Chao

Qingbei Zeng

Yuhua Huang

Jianhua Cao

Wanli Wu

Siska Hendrata

Mwangi Wa Mutahi

Joseph A Kozlowski

Bernard R Neustadt

Brian Alexander McKittrick

Alan K Mallams

Wensheng Yu

M Arshad Siddiqui

Janeta Popovici-Muller

Younong Yu

Dansu Li

Gerald Wayne Shipps, Jr

Sunil Paliwal

Brian J Lavey

Purakkattle J Biju

Zhuyan Guo

Robert D Mazzola, Jr

Vinay M Girijavallabhan

Peter Orth

Jesse K Wong

Guowei Zhou

Jonathan A Pachter

Lianyun Zhao

Latha G Nair

Wei Zhou

Kristin E Rosner

Chaoyang Dai

David Benjamin Belanger

Jinping L McCormick

Bimalendu Dasmahapatra

Shing-Chun C Wong

Srinkanth Venkatraman

Mark Demma

Viyyoor M Girijavallabhn

Marguerita Lim-Wilby

Edwin E Jao

Tejal N Parekh

Disclosed are novel compounds of the formula or a pharmaceutically acceptable salt thereof, wherein: 

[object Object]

The present invention provides compositions as well as methods for identifying compositions useful for treating or preventing cancer.

p53 modulators

This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, TNF-&#x3b1; or combinations thereof.

Compounds for the treatment of inflammatory disorders

Disclosed are compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein:

The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Peptides as NS3-serine protease inhibitors of hepatitis C virus

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Disclosed are novel compounds of the formula  Also disclosed are pharmaceutical compositions comprising the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I in combination with a Hreceptor antagonist.

Piperidine compounds

Disclosed are novel compounds of the formula Also disclosed are pharmaceutical compositions comprising the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I in combination with a H. receptor antagonist.

Growing community of inventors

South Plainfield, NJ, United States of America

Henry A Vaccaro